OBJECTIVE: It has been shown previously in smaller studies that fasting serum leptin and insulin concentrations are highly correlated, and insulin sensitive men have lower leptin levels than insulin resistant men matched for fat mass. We have examined the association between insulin resistance (assessed by fasting insulin) and leptin after controlling for overall and central adiposity in a population-based cohort. DESIGN: Leptin levels were compared across insulin resistance quartiles within three categories of obesity (tertiles of body mass index (BMI)). Partial correlation coef®cents and multiple linear regression models were used to assess the relationship between leptin and fasting insulin after adjusting for BMI and waist to hip ratio (WHR) or waist circumference. SUBJECTS: Subjects were normoglycemic participants of a 1987 non-communicable diseases survey conducted in the multiethnic population of Mauritius. 1227 men and 1310 women of Asian Indian, Creole and Chinese ethnicity had normal glucose tolerance and fasting serum leptin measurements. RESULTS: Mean serum leptin concentration increased across quartiles of fasting insulin in each BMI group and gender, after controlling for BMI, WHR and age. Furthermore, fasting insulin was a signi®cant determinant of serum leptin concentration, independent of BMI and WHR, in both men and women. Similar results were found if waist circumference replaced BMI and WHR in the model. CONCLUSION: These results suggest that insulin resistanceaconcentration may contribute to the relatively wide variation in leptin levels seen at similar levels of body mass or alternatively, leptin may play a role in the etiology of insulin resistance. Further studies will be important to determine whether the hyperleptinemiaainsulin resistance relationship has a role in the natural history of obesity, Type 2 diabetes mellitus and the other metabolic abnormalities associated with insulin resistance.
Introduction
Leptin, the circulating product of the recently discovered ob gene, may be a critical factor in the control of energy stores. The effects of leptin suggest regulation of energy balance at the hypothalamic level, 1 and leptin receptors have now been demonstrated in the choroid plexus. 2 Leptin treatment causes dramatic reductions in food intake and body weight in rodents. 3±5 However, only the obese (obaob) mouse 3, 4 lacks circulating leptin, whereas other animal models of obesity. 5±7 and obese humans 8±10 show hyperleptinemia.
The effects of short and long term insulin infusions on leptin production have been studied, 11 and while the results suggest that ob gene expression and leptin production are indirectly regulated by insulin, 12 more detailed studies are needed. Certainly, a strong positive correlation exists between leptin and insulin concentrations, 10±14 and insulin sensitive men have lower leptin concentrations than those with insulin resistance, independent of body fat mass. 15 This raises important questions about the potential role of leptin in the modulation of insulin sensitivity, or vice versa.
The interrelationship of leptin and insulin sensitivity is confounded by the strong association between leptin and obesity 6,8±10 and the effect of obesity on insulin sensitivity, 16 indicating the need to control for the effect of obesity. In addition, much of human leptin research so far has been based on small clinical studies. 8,9,13±15 This study aimed to evaluate the relationship between insulin sensitivity and leptin concentration independent of obesity in data from a large epidemiological study of diabetes and cardiovascular (CVD) disease in the multiethnic population of Mauritius. 17 
Research design and methods
Subjects. The subjects were drawn from a populationbased non-communicable disease survey performed in Mauritius in 1987 and are described in detail elsewhere. 17, 18 Mauritius is an island nation located in the southwestern Indian Ocean. The multiethnic population comprises about 70% of Asian Indian origin, 27.9% Creole (mixed with mainly African ancestry) and 2.1% Chinese. The survey protocol was reviewed and approved by the Alfred Healthcare Group Ethics Committee (Melbourne, Australia) and consent of the subjects for leptin measurement was inferred from their voluntary participation.
Survey procedure and analyses. All adults aged 25± 74 y were eligible to attend the survey if resident in the population clusters chosen in the representative sample. 17 Subjects presented to a survey site between 08:00 and 10:00 h after an overnight fast. All subjects not using oral hypoglycaemic tablets or insulin, underwent an oral glucose tolerance test (75 g dextrose monohydrate). Fasting and 2 h blood samples were collected and plasma glucose was measured on site using a glucose analyser (YSI, Yellow Springs, OH). Glucose tolerance status was classi®ed according to WHO recommendations. 19 Body mass index (BMI) was calculated as kgam 2 and waist and hip girth were measured in duplicate to calculate waist to hip ratio (WHR) from the means of measurements as previously described. 18 Eligibility for the present study was limited to 1227 men and 1310 women who had normal glucose tolerance 19 in 1987, and who also attended a followup survey in 1992. Serum leptin levels were only available for those who participated in both surveys. Leptin measurements on sera frozen since 1987 (720 C), were performed in 1996, using radioimmunoassay kits (Linco, St Louis, MO). Insulin values for the same subjects were measured in 1987 on frozen sera using an in-house assay. 20, 21 Interassay and intraassay coef®cients of variation were 6% and 4%, respectively. Cross-reactivity with intact proinsulin and 32,33-split proinsulin was 27% and 16%, respectively. There was`5% difference between results obtained with this assay and a highly speci®c enzymelinked immunosorbent assay. Fasting insulin was used as a marker of insulin sensitivity. It has previously been shown that in non-diabetic subjects fasting insulin is closely correlated with more direct measures of insulin resistance. 22 Statistical analysis. All analyses were performed using the Statistical Package for the Social Sciences. 23 Spearman rank correlation coef®cients were calculated between all variables using a 2-tailed test for signi®cance. The relationship of serum leptin concentration to insulin resistance was examined within gender-speci®c tertiles of BMI. For men, the cut-off points to de®ne the tertiles were 21.0 and 24.0 kgam 2 and for women they were 21.1 and 25.0 kgam 2 . Within each tertile of BMI, gender-speci®c distributions of fasting insulin were divided into quartiles. Mean levels of serum leptin were calculated across quartiles of fasting insulin adjusting for differences in age, BMI and WHR by analysis of covariance. The signi®cance of differences across groups was assessed by the F-test. Log 10 transformation was used to normalize distributions of leptin, fasting glucose and fasting insulin, and mean values were back-transformed for presentation. The independent linear relationship between log 10 leptin and log 10 fasting insulin was assessed using all subjects after adjusting for age, BMI, WHR and log 10 fasting glucose in multiple linear regression models calculated for men and women separately. Partial correlations of fasting insulin with leptin were calculated as the other variables were sequentially added to the model. These models were also used to calculate the overall R 2 and signi®cance of changes in R 2 as the independent variables were added. Similar linear regression models using waist circumference instead of BMI and WHR were also calculated. In an alternative analysis, insulin sensitivity computed using the Homeostasis Model Assessment (HOMA) model 24 was used instead of fasting insulin. Table 1 shows the mean levels of selected variables in the study subjects. Men were leaner (according to BMI), but had higher mean WHR and waist circumference than women. All subjects had normal glucose tolerance (by selection), although mean fasting glucose levels were higher in men than women. Women had higher fasting insulin concentration and also were more insulin resistant on the basis of HOMA than men. Mean serum leptin levels were about 3-fold higher in women than men (10.2 vs 3.4 ngaml).
Results
To assess associations between the variables used in later multivariate analyses, Table 2 shows Spearman correlation coef®cients between the anthropometric and metabolic variables. Insulin sensitivity calculated from the HOMA model was very strongly correlated with fasting insulin in both men and women. Leptin was signi®cantly correlated with each of the anthropmetric variables, although the relationship with WHR was not as strong as with BMI or waist circumference. Strong correlations were also observed between leptin and the metabolic variables, except fasting glucose. Figure 1 depicts age-, BMI-and WHR-adjusted geometric mean leptin according to quartiles of fast-ing insulin within categories of obesity. At each level of obesity, and in both men and women, there was a highly signi®cant increase in mean leptin levels with increasing insulin resistance (P`0.001 for each comparison). It can also be seen from Figure 1 , that leptin levels increase across BMI categories (note the difference in the magnitude of the scales of the leptin axes between BMI groups). This analysis was repeated for each ethnic group separately (data not shown) and the relationship between fasting insulin and leptin was consistent for each of Indians, Creoles and Chinese, although differences across fasting insulin were not statistically signi®cant in Chinese, due to small numbers.
To assess the linear relationship between leptin and fasting insulin across the entire range of obesity, multiple linear regressions were performed with leptin (log 10 ) as the dependent variable, on men and women separately (Table 3) . Partial correlation coef®cients for insulin, adjusting for the other independent variables are presented along with R 2 for the models. The partial correlation coef®cient for fasting insulin alone was about 0.5 in both men and women but was reduced to about half by adjustment for BMI. Further adjustment for age, fasting glucose and WHR did not alter the magnitude of the partial correlation coef®-cient. The models shown in Table 3 explained 43% and 53% of the variation in leptin in men and women, respectively. If BMI and WHR were replaced with waist circumference 44% and 48% of this variation was explained. A BMI by fasting insulin interaction term was also tested, but was not signi®cant in either gender. Models using insulin resistance from the HOMA model rather than fasting insulin concentration showed very similar results.
Discussion
This study, in a large population-based cohort, con®rms results of clinic-based investigations 14, 15 and our ®ndings in another population, 10 that insulin resistance (as indicated by fasting insulin concentration) is associated with elevated leptin concentrations independent of adiposity and fat distribution. More insulin resistant subjects had leptin levels consistently higher than insulin sensitive subjects regardless of gender or level of obesity, and this was true in each ethnic group. Linear regression models con®rmed the associations observed within BMI tertiles. Consistent with earlier reports, 8±10 mean leptin concentration was substantially higher in obese than lean Mauritian subjects, and women had leptin levels at least three times higher than men. Moreover, the large variation in leptin at similar levels of BMI suggests that factors besides obesity are important in regulating serum leptin.
8±10 Insulin sensitivity appears to be one such factor.
Testosterone levels or the ratio of androgenaestrogen have recently been observed to correlate negatively with leptin concentrations in men independent of BMI, 25 suggesting another possible factor contributing to variations in leptin. This observation may also be important in explaining maleafemale differences in leptin levels which persist after adjusting for body fat in some studies, and do not appear to be explained by levels of female reproductive hormones.
26±30
The HOMA model has been suggested as a useful tool for assessing insulin sensitivity in large epidemiological studies, where it is prohibitive, both economically and practically, to undertake more complex assessments of insulin sensitivity. 31, 32 HOMA estimates of insulin resistance have been shown to correlate well with more direct methods. 33 However, when HOMA derived insulin sensitivity is strongly correlated with fasting insulin, as observed in this population, it is not adding any extra information. Haffner and colleagues 34, 35 have reported similar high correlation coef®cients for HOMA insulin sensitivity and fasting insulin in the Mexico City Diabetes Study and San Antonio Heart Study populations, concluding that the HOMA model may be most useful for estimating b-cell function. Thus it is not surprising that similar results were obtained, whether HOMA insulin sensitivity or fasting insulin were used.
To account for the confounding effect of obesity on leptin and insulin sensitivity, Segal et al 15 assessed the relationship speci®cally in 18 lean insulin sensitive and resistant men matched closely for body fat mass. Insulin sensitivity was classi®ed using an intravenous glucose tolerance test and minimal model analysis. Leptin was signi®cantly lower in the lean insulin sensitive subjects than in those who were relatively insulin resistant. Our study uses indirect estimates of both insulin resistance and fat mass but given the magnitude of the observed difference, it seems unlikely that this effect would be lost if more direct measures were used. Moreover, the association of insulin sensitivity and leptin, independent of BMI and WHR or waist circumference, was seen over the entire population range of BMI (not just in lean subjects), and in both men and women.
There is a possibility that the contribution of adipose tissue to leptin levels was not being fully accounted for by adjusting for BMI and WHR. In fact, there was a trend for increasing waist circumference with insulin resistance, after correcting for BMI (data not shown), although it was not possible to adjust for both BMI and WHR when assessing waist circumference, due to collinearity. However, Segal's study assessing the effect of adipose tissue mass with more sophisticated methods such as densitometry con®rms the independence of the relationship of leptin with measures of insulin resistance. 15 A number of other studies have examined the relationship between leptin and insulin resistance or insulin concentration independent of obesity with con¯icting results. Havel et al 36 found that leptin was correlated with fasting insulin in women over a range of BMI, but after adjusting for BMI or percent body fat this relationship was no longer signi®cant. In Figure 1 Age-, BMI-and WHR-adjusted mean leptin levels according to quartiles of fasting insulin within obesity groups (BMI tertiles) in Mauritian men and women. ***P`0.001 across insulin resistance quartiles.
Leptin and insulin sensitivity PZ Zimmet et al
African-American women, leptin was not correlated with insulin sensitivity (by intravenous glucose tolerance test) after adjusting for body fat mass by dualenergy X-ray absorbtiometry (DEXA). 37 Studies by Larsson et al, 38 Kohrt et al 39 and Turpeinen et al 40 also found that insulin or insulin sensitivity did not correlate with leptin, independent of obesity, measured by impedance, DEXA or infra-red densitometric assay, respectively, in subjects with normal or impaired glucose tolerance. However, in support of our ®ndings, leptin was independently related to insulin sensitivity (hyperinsulinaemic, euglycaemic clamp) after adjusting for body fat percentage in Danish men and women, 30 and in a large epidemiological study, leptin levels were related to fasting insulin independently of BMI. 41 None of the positive results discussed so far have indicated the relative strength of the relationships between leptin and insulin concentration or insulin sensitivity. As these two parameters are closely correlated in most populations, it is dif®cult to differentiate between them. Both fasting insulin and insulin sensitivity (hyperinsulinaemic, euglycaemic clamp) were correlated with leptin independently of BMI in middle-aged Finnish men, but no attempt was made to assess which was more important. 42 In subjects with Type 2 diabetes mellitus, the association between insulin concentration and resistance is not as close, and in two studies making use of this phenomenon, leptin was found to be more closely correlated with insulin concentration than with insulin resistance. These inconsistent results indicate the need to standardize the approach to investigations into leptin, insulin and obesity.
Results from a cross-sectional study such as this do not reveal the direction of the association between leptin and insulin resistance. However, recent studies have shed some light on the possible effects of insulin andaor insulin resistance on leptin. Insulin has been shown to be a potent regulator of leptin gene expression in cultured human adipocytes and to induce increased leptin production. 12 Clinical studies of the effects of insulin on leptin also show mixed results. In some studies, no short-term effect was observed, 11, 13, 14 although Kolaczynski et al 11 demonstrated that in the long-term (48±72 h) insulin may regulate ob gene expression and leptin production indirectly, possibly via a trophic effect on adipocytes. More rapid, although not acute, responses of leptin to insulin have also been observed. In normal and Type 2 diabetic subjects, leptin levels were increased by 8.5 h of hyperinsulinemic clamp, 43 and leptin levels were increased after only 4 h of supraphysiological hyperinsulinaemia in lean normal subjects. 44 However, the lack of acute effects of insulin on leptin implies that post-prandial satiety is not regulated by leptin, 44 although insulin may be important in long-term leptin regulation. 11, 43, 44 On the other hand, ®ndings from a study using human liver cells have suggested that leptin when administered in concentrations similar to that found in obesity, antagonizes insulin signaling. 45 This led the authors to conclude that secretion of leptin by adipose tissue may be a mechanism whereby adiposity causes insulin resistance. In the Israeli Sand rat (Psammomys obesus), a model of Type 2 diabetes, leptin has been reported to inhibit insulin binding to adipocyte insulin receptors, offering another mechanism whereby hyperleptinaemia could contribute to insulin resistance in obesity. 46 At the genetic level, the leptin receptor and acute insulin response loci appear to be closely co-localised on chromosome 1, as demonstrated in Pima Indians. 47 It has been suggested therefore, that the leptin receptor gene could play a secondary role in regulation of the acute insulin response (AIR), with high leptin levels down-regulating the receptor gene and diminishing AIR, which may in turn have implications for insulinaemia and insulin sensitivity. However, if leptin and insulin are acting as part of a feed-back loop controlling adipose tissue mass, each could modulate the other simultaneously. Direct effects of leptin on insulin sensitivity at the insulin receptor have yet to be examined in humans. Only studies investigating the effect of leptin administration, once leptin is available for human use, on insulin concentrations or insulin sensitivity, will help to clarify these associations.
In conclusion, our ®ndings in a large populationbased sample are consistent with a biological link between leptin and insulin. They also suggest that there are determinants of serum leptin concentration beside body fat. Insulin resistance or insulin concentration per se, or via determinants including genetic, biological and environmental factors 16, 31 may modulate leptin concentration. Alternatively, leptin itself may have an important role in the determination of insulin resistance in the liver, 45 or through interactions with the insulin receptor. 46 Our ®ndings of a strong association between leptin and a marker for insulin sensitivity independent of obesity suggest an important role for leptin in human metabolism. Further studies on the dynamics of the relationship between leptin, insulin and adipose tissue are required to clarify the underlying importance of leptin. Prospective epidemiological studies will also be required to assess the possible role of leptin in the natural history of obesity and glucose intolerance.
